Bio Stocks™@BioStocks

2 years ago

Court Finds $UTHR Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million. $LQDA https://t.co/dSld3WTTPB

No $ gain for $LQDA but a good hit against $UTHR and warning to them once Yutrepia comes to market. https://t.co/X1z3D1LVwR

$LQDA Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million https://t.co/rGkMWXCRnE